Amphora Medical said today it closed a $35.5 million Series B financing round, led by major medtech player Boston Scientific (NYSE:BSX), with funds slated to support a US pivotal trial of its Selective Bladder Denervation System for treating women with overactive bladder. Amphora’s Selective Bladder Denervation System is a minimally-invasive, cystopic device which uses targeted ablation […]
Amphora Medical
Stealthy Amphora Medical lands $13m
Amphora Medical said in a regulatory filing that it raised just more nearly $13 million for the radiofrequency ablation device it’s developing to treat overactive bladder. Eight unnamed investors put $12.8 million into the Maple Grove, Minn.-based company, according to the July 13 filing. Amphora Medical launched the Series A round in May 2013, initially raising about $6 million, […]